Moderna to provide 500 million vaccine doses for Covax programme
The advance purchase agreement comes just days after the World Health Organisation announced emergency approval for the vaccine. By Garreth MacNamee Monday 3 May 2021, 7:10 PM 4 hours ago 32,378 Views 11 Comments
Image: PA
Image: PA
MODERNA AND VACCINE promoter Gavi have announced a deal by which the pharmaceutical company will provide up to 500 million doses for the UN-backed Covax programme by the end of 2022.
The advance purchase agreement comes just days after the World Health Organisation (WHO), after weeks of delays, announced emergency approval for the Moderna vaccine that will pave the way for its rollout in Covax.
VAX LIVE Surpasses Campaign Goal With More Than 10 Million COVID-19 Vaccine Doses Pledged
Global Citizens helped mobilize $53.8M in commitments so far, a week before VAX LIVE airs May 8.
Why Global Citizens Should Care
The COVID-19 pandemic cannot end until all countries have access to lifesaving vaccine doses. Initiatives like COVAX can ensure COVID-19 vaccines reach every person that needs them, but not without support from government leaders, corporations, philanthropists, and Global Citizens everywhere demanding vaccine equity. Join us by taking action to end the pandemic here.
As part of
VAX LIVE: The Concert to Reunite the World, Global Citizen on Sunday surpassed the campaign goal of securing 10 million COVID-19 vaccine doses to help the world s most marginalized communities and health care workers access the vaccine.
Moderna to supply 500 million COVID-19 vaccine doses to poorer countries through WHO initiative
By Jamey Keaten article
SAN ANTONIO, TX - MARCH 29: A nurse fills up a syringe with the Moderna COVID-19 vaccine at a vaccination site at a senior center on March 29, 2021 in San Antonio, Texas. Texas has opened up all vaccination eligibility to all adults starting today. T
Expand
U.S. biotech company Moderna will provide up to 500 million doses for the U.N.-backed program to ship coronavirus vaccines to needy people in low- and middle-income countries, but shipments won t begin until the fourth quarter, the company and program leaders said Monday.
. GENEVA U.S. biotech company Moderna will provide up to 500 million doses for the U.N.-backed program to ship coronavirus vaccines to needy people in low- and middle-income countries, but shipments won t begin until the fourth quarter, the company and program leaders said Monday. The advance purchase agreement from Gavi, the Vaccine Alliance, comes just days after the World Health Organization announced emergency approval of the Moderna vaccine that paves the way for its inclusion in the U.N.-backed COVAX program. Gavi, a Geneva-based public-private partnership, has been scrambling to try to strike deals with vaccine makers at the same time as trying to persuade rich countries that have secured millions of doses some of which they aren t even using to donate them to poorer ones.
In this file photo dated April 14, 2021, a pharmacist fills a syringe from a vial of the Moderna COVID-19 vaccine in Antwerp, Belgium. (Virginia Mayo/AP FILE)
Cambridge-based biotech company Moderna will provide up to 500 million doses for the U.N.-backed program to ship coronavirus vaccines to needy people in low- and middle-income countries, but shipments won’t begin until the fourth quarter, the company and program leaders said Monday.
The advance purchase agreement from Gavi, the Vaccine Alliance, comes just days after the World Health Organization announced emergency approval of the Moderna vaccine that paves the way for its inclusion in the U.N.-backed COVAX program.